Posts about "colon cancer"

A landmark Scandinavian study demonstrates that low-dose aspirin can significantly reduce the recurrence of colon and rectal cancer in patients with certain genetic mutations, positioning it as a promising precision medicine option.

A groundbreaking study led by the Karolinska Institutet indicates that a low-cost, low-dose aspirin could dramatically reduce the recurrence of colorectal cancer in patients with specific genetic markers.